Andreas Jung
4PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Nov 19, 2022
Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistance.Lucien Torlot, Anna Jarzab, Johanna Albert
|Sep 18, 2020
Amphiregulin Expression Is a Predictive Biomarker for EGFR Inhibition in Metastatic Colorectal Cancer: Combined Analysis of Three Randomized Trials.Arndt Stahler, Sebastian Stintzing, Dominik P Modest
|Aug 16, 2018
Validation of miR-31-3p Expression to Predict Cetuximab Efficacy When Used as First-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer.Pierre Laurent-Puig, Marie-Lise Grisoni, Volker Heinemann
|May 18, 2018
Targeting tumor cell plasticity by combined inhibition of NOTCH and MAPK signaling in colon cancer.Eva Marina Schmidt, Sebastian Lamprecht, Cristina Blaj
Pageof 1
